| Acquirer | Target | Price |
|---|---|---|
| Agilent Technologies Inc. | Seahorse Bioscience | $235 million |
| Concordia Healthcare Corp. | Amdipharm Mercury Limited | $3.3 billion |
| Eprirus Biopharmaceuticals, Inc. | Bioceros Holding B.V. | $14.1 million |
| Biogen Inc. | License to MT-1303 | $60 million |
| Apricus Biosciences, Inc. | U.S. rights to Vitaros™ | $1 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
